---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-086142"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T04:29:10.962516+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Anzu Special Acquisition loses CFO, GC, two board members including chair; Nasdaq non-compliance triggered

## Summary
- CFO John Joy and GC Peter Ganz resigned July 29-31, 2022; Joy effective after Q2 10-Q filing, Ganz effective July 31.
- Board members Teresa Harris (July 29) and Chairman William Wulfsohn (July 31) resigned citing disagreement with company decisions, pursuit of a specific target, and loss of executives.
- Resignations reduce board from 5 to 3; Nasdaq notified of non-compliance with audit committee independence rule (Listing Rule 5605(c)(2)(A)).
- Company has no pending letter of intent and no assurance of completing a business combination; cure period available for Nasdaq compliance.

## SEC filing metadata
- accession: 0001104659-22-086142
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000110465922086142/0001104659-22-086142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000110465922086142/tm2222543d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-086142
- JSON: https://secwatch.observer/filing/0001104659-22-086142.json
- Plain text: https://secwatch.observer/filing/0001104659-22-086142.txt

## Key facts
- Executive change
  John W. Joy resigned as Chief Financial Officer at Envoy Medical, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On July 29, 2022, John W. Joy notified the Company of his intention to resign from his position as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000110465922086142/0001104659-22-086142-index.htm
- Executive change
  William Wulfsohn resigned as Chairman of the Board at Envoy Medical, Inc..
  - Action: resigned
  - Role: Chairman of the Board
  source text: On July 31, 2022, William Wulfsohn notified the Company of his resignation as a member of the Board effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000110465922086142/0001104659-22-086142-index.htm
- Executive change
  Peter J. Ganz resigned as General Counsel & Corporate Secretary at Envoy Medical, Inc..
  - Action: resigned
  - Role: General Counsel & Corporate Secretary
  source text: On July 29, 2022, Peter J. Ganz notified the Company of his resignation from his position as General Counsel & Corporate Secretary of the Company effective July 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000110465922086142/0001104659-22-086142-index.htm
- Executive change
  Teresa A. Harris resigned as Director at Envoy Medical, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 29, 2022, Teresa A. Harris notified the Company of her resignation as a member of the Board effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000110465922086142/0001104659-22-086142-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.